NCT02782026View on ClinicalTrials.gov

Exhaled Breath Olfactory Signature of Pulmonary Arterial Hypertension

NACompletedINTERVENTIONAL
Enrollment

273

Participants

Timeline

Start Date

March 4, 2016

Primary Completion Date

August 28, 2018

Study Completion Date

September 4, 2018

Conditions
Pulmonary Hypertension
Interventions
DEVICE

Exhaled Breath Olfactory Signature (Artificial Nose)

Trial Locations (1)

94275

AP-HP, Bicêtre Hospital, Le Kremlin-Bicêtre

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Technion, Israel Institute of Technology

OTHER

collaborator

Bayer

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER